Bellevue Life Sciences AcquiBLACU
13F holders, Q1 2024 (March 31)2holders
$11.28avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Bellevue Life Sciences Acqui (BLACU) in their 13F filings. The largest holders were Clear Street LLC ($42K) and Tower Research Capital LLC (TRC) ($110).
- Company
- Bellevue Life Sciences Acqui
- CUSIP
- 079174207
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 2 holders
| Clear Street LLC | 0.00% | Add +3660.0% | 3,760 | $42K |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 10 | $110 |
"% of holder's portfolio" is BLACU's weight in each manager's 13F, not the share of Bellevue Life Sciences Acqui the manager owns.